Filtra per Last updated date SelectDopoPrimaFrom - To Date Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Esito (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Committee for veterinary medicinal products: Meeting of 11 to 13 March 2003 14 Marzo 2003Press releaseVeterinary European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 18 to 20 February 2003 24 Febbraio 2003Press release EMEA Management Board elects new chairman and sets out proposed work programme for 2004 21 Febbraio 2003Press releaseCorporate Committee for veterinary medicinal products: Meeting of 11 to 13 February 2003 14 Febbraio 2003Press releaseVeterinary 32nd meeting of the Committee for Orphan Medicinal Products 11 Febbraio 2003Press releaseHumanRare diseases European Agency for the Evaluation of Medicinal Products: EudraLink Launch meeting 28-29 January 2003 5 Febbraio 2003Press release Public statement on the increased risk of serious infection and neutropenia in patients treated concurrently with Kineret (anakinra) and Enbrel (etanercept) 5 Febbraio 2003News European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 21 to 23 January 2003 23 Gennaio 2003Press release Committee for veterinary medicinal products: Meeting of 14 to 16 January 2003 17 Gennaio 2003Press releaseVeterinary 31st meeting of the Committee for Orphan Medicinal Products 13 Gennaio 2003Press releaseHumanRare diseases 1 … 350 351 352 353 354 Page 354 of 383 355 356 357 358 … 383
Committee for veterinary medicinal products: Meeting of 11 to 13 March 2003 14 Marzo 2003Press releaseVeterinary
European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 18 to 20 February 2003 24 Febbraio 2003Press release
EMEA Management Board elects new chairman and sets out proposed work programme for 2004 21 Febbraio 2003Press releaseCorporate
Committee for veterinary medicinal products: Meeting of 11 to 13 February 2003 14 Febbraio 2003Press releaseVeterinary
32nd meeting of the Committee for Orphan Medicinal Products 11 Febbraio 2003Press releaseHumanRare diseases
European Agency for the Evaluation of Medicinal Products: EudraLink Launch meeting 28-29 January 2003 5 Febbraio 2003Press release
Public statement on the increased risk of serious infection and neutropenia in patients treated concurrently with Kineret (anakinra) and Enbrel (etanercept) 5 Febbraio 2003News
European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 21 to 23 January 2003 23 Gennaio 2003Press release
Committee for veterinary medicinal products: Meeting of 14 to 16 January 2003 17 Gennaio 2003Press releaseVeterinary
31st meeting of the Committee for Orphan Medicinal Products 13 Gennaio 2003Press releaseHumanRare diseases